Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Jan 24, 2012
0
0
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other ...
Sep 22, 2011
0
0
In the state of Washington, a planned home birth with a licensed midwife is just as safe as a birth at a licensed birth center.
Oct 8, 2021
0
17
As teens prepare to leave home for college or live on their own in a new city, many may also be using ride sharing services for the first time—and that raises safety concerns for many parents—a new national poll suggests.
Apr 15, 2019
0
0
The European Medicines Agency said it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19.
Nov 23, 2021
0
26
In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced ...
Mar 18, 2019
0
1
The use of license plate decals for drivers with learner permits doesn't seem to have reduced their crash rate in New Jersey, the first US state to introduce the regulation, finds research published online in the journal ...
Jun 29, 2015
0
7
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, ...
Aug 9, 2023
0
40
New research into the impact of tobacco retailer licensing fees on tobacco availability has prompted public health experts to call on all Australian Governments to adopt a higher minimum standard of licensing regulation nationally ...
Sep 22, 2023
0
2
The Malaghan Institute of Medical Research, in collaboration with Wellington Zhaotai Therapies Limited, today announced results of its phase 1 dose escalation trial of a new third generation anti-CD19 chimeric antigen receptor ...
Dec 11, 2023
0
0
